modelling the schizophrenic brain

1
For personal use. Only reproduce with permission from The Lancet Publishing Group. THE LANCET Neurology Vol 1 August 2002 http://neurology.thelancet.com 208 Why are we not all deluded? What keeps us from experiencing the hallucinations that plague people with schizophrenia? These were some of the questions posed at a recent Novartis Foundation meeting (May 27, 2002, London, UK). Apparently, the boundaries of normality can be flimsy: up to 4% of people in Britain have heard a voice in the last year, and as many as 17% of the Dutch population have experienced an isolated delusion. Psychiatrists believe that social interactions anchor our thoughts within the realms of accept- ability and compelling evidence from animal models now suggests that isolation may play a critical role in the development of schizophrenia. “It is a deprivation of social play, at a time where it has a crucial effect”, says Trevor Robbins (University of Cambridge, Cambridge, UK). “There is a window of vulnerability in early childhood and early puberty”, he adds. Robbins’ team has seen that rats reared in isolation develop similar cognitive defects to those observed in patients with schizophrenia: their prepulse inhibition (PPI)—a normal inhibition of the startle reflex—drops and their behavioural flexibility is impaired. In addition, Robbins has found alterations in the hippocampus, amygdala, and prefrontal cortex of these rats. That social isolation can exert such a profound impact is at odds with the ‘doomed from the womb’ hypothesis, which views schizophrenia as a purely neurodevelopmental disorder—the result of an early lesion to the hippocampus. Yet the isolation theory rings true with psychiatrists who spend most of their time trying to get their patients with schizophrenia to engage socially. But while the pathophysiology of schizophrenia remains an enigma, most agree the illness is an un- fortunate marriage of genetics and the environment. Undoubtedly genes have a major effect, but there is also a strong influence of environmental factors, in particular those affecting the human fetal brain during the second trimester of gestation. Maternal viral infections, mal- nutrition, and stress can precipitate the disease in susceptible people. The link between all three, Jim Koenig (University of Maryland School of Medicine, Baltimore, MD, USA) suggests, is an over-stretched hypo- thalamic–pituitary–adrenal (HPA) axis. “We know there are abnor- malities in the HPA axis in some patients”, he stressed. Koenig has developed a rat model that displays striking similarities with the human disease. Animals that are prenatally stressed display many symptoms of schizophrenia on reaching adulthood such as reduction in working memory, loss of hippoccampal volume, loss of social behaviour, disrupted PPI, and, crucially, the onset of behavioural changes after puberty. “This may be a very valuable heuristic model for learning more about schizophrenia in humans”, enthuses Koenig. One peculiarity of schizophrenia is that symptoms emerge after puberty, with no warning signs. The Lipska animal model—in which neonatal rat pups are injected with the neurotoxin ibotenic acid into the ventral hippocampus on day 7— replicates this peculiar feature. The timing of this insult corresponds with the end of the second trimester of pregnancy in humans. Jean-Luc Moreau (F Hoffman-La Roche, Switzerland) has replicated the Lipska model and found that in adulthood, “these lesioned rats have long-lasting deficits in their capacity to acquire and retain information in spatial and learning tests”, a characteristic also found in people with schizophrenia. Moreau has gone one step further and used this model to test antipsychotic drugs. Clozapine, olanzapine, and risperidone reverse the defects in PPI whereas haloperidol does not, a situation that reflects the clinic where some patients only respond to atypical antipsychotics. But how well does this model mimic real life? Of course, people with schizophrenia have not had a hippo- campal injection of toxin shortly after birth, but they often have perinatal complications, low birth weight, or hypoxia. “You could imagine that this lesion in the hippocampus [in rats] is crudely modeling what might happen to the hippocampus of a human as a result of some obstetric event causing hypoxia”, says Robin Murray (Institute of Psychiatry, London, UK). The added bonus of looking at animal models is that some rodent strains are more susceptible to environmental triggers than others—a powerful indication that genes deal the deciding hand. Yet opinions remain divided as to how much is attributable to genetics. Murray insists that genes and early environmental insults, separately, are not enough. “Clearly lots of the population are born prematurely or with complications and never develop schizophrenia. However, the effects of such hazards on an individual with genetic predisposition seems to result in aberrant brain circuitry which cannot cope with stresses such as isolation or drug abuse”, he says. Will it ever be possible to model schizophrenia? It is unlikely that researchers will ever know whether a rat hallucinates or a mouse hears alien voices. Schizophrenia is such a com- plex disorder that, in practice, it may be impossible to mimic all the symptoms in a single animal. Despite the limitations, current models are already providing some new insights. “The animal models are more sophisticated than I had anticipated”, says Murray. “My view used to be that it was too ambitious to model schizophrenia. But I now see that you don’t model schizophrenia but aspects of the syndrome.Lisa Melton Modelling the schizophrenic brain Newsdesk Shrunken hippocampi in schizophrenia Dr Nancy C Andreasen/Science Photo Library Rights were not granted to include this image in electronic media. Please refer to the printed journal.

Upload: lisa-melton

Post on 19-Sep-2016

215 views

Category:

Documents


3 download

TRANSCRIPT

For personal use. Only reproduce with permission from The Lancet Publishing Group.

THE LANCET Neurology Vol 1 August 2002 http://neurology.thelancet.com208

Why are we not all deluded? Whatkeeps us from experiencing thehallucinations that plague people withschizophrenia? These were some ofthe questions posed at a recentNovartis Foundation meeting (May27, 2002, London, UK). Apparently,the boundaries of normality can beflimsy: up to 4% of people in Britainhave heard a voice in the last year, and as many as 17% of the Dutchpopulation have experienced anisolated delusion. Psychiatrists believethat social interactions anchor ourthoughts within the realms of accept-ability and compelling evidence fromanimal models now suggests thatisolation may play a critical role in thedevelopment of schizophrenia.

“It is a deprivation of social play,at a time where it has a crucial effect”,says Trevor Robbins (University ofCambridge, Cambridge, UK). “Thereis a window of vulnerability in earlychildhood and early puberty”, headds. Robbins’ team has seen that ratsreared in isolation develop similarcognitive defects to those observed inpatients with schizophrenia: theirprepulse inhibition (PPI)—a normalinhibition of the startle reflex—dropsand their behavioural flexibility isimpaired. In addition, Robbins hasfound alterations in the hippocampus,amygdala, and prefrontal cortex ofthese rats.

That social isolation can exert sucha profound impact is at odds with the‘doomed from the womb’ hypothesis,which views schizophrenia as a purelyneurodevelopmental disorder—theresult of an early lesion to thehippocampus. Yet the isolation theoryrings true with psychiatrists whospend most of their time trying to gettheir patients with schizophrenia toengage socially.

But while the pathophysiology ofschizophrenia remains an enigma,most agree the illness is an un-fortunate marriage of genetics and theenvironment. Undoubtedly geneshave a major effect, but there is also astrong influence of environmentalfactors, in particular those affectingthe human fetal brain during thesecond trimester of gestation.

Maternal viral infections, mal-nutrition, and stress can precipitatethe disease in susceptible people. Thelink between all three, Jim Koenig(University of Maryland School ofMedicine, Baltimore, MD, USA)suggests, is an over-stretched hypo-thalamic–pituitary–adrenal (HPA)axis. “We know there are abnor-malities in the HPA axis in somepatients”, he stressed.

Koenig has developed a rat modelthat displays striking similarities withthe human disease. Animals that areprenatally stressed display many

symptoms of schizophrenia onreaching adulthood such as reductionin working memory, loss ofhippoccampal volume, loss of socialbehaviour, disrupted PPI, and,crucially, the onset of behaviouralchanges after puberty. “This may be avery valuable heuristic model forlearning more about schizophrenia inhumans”, enthuses Koenig.

One peculiarity of schizophrenia isthat symptoms emerge after puberty,with no warning signs. The Lipskaanimal model—in which neonatal ratpups are injected with the neurotoxinibotenic acid into the ventralhippocampus on day 7— replicates thispeculiar feature. The timing of this insult corresponds with the end of the second trimester of pregnancy in humans. Jean-Luc Moreau(F Hoffman-La Roche, Switzerland) hasreplicated the Lipska model and foundthat in adulthood, “these lesioned ratshave long-lasting deficits in theircapacity to acquire and retaininformation in spatial and learningtests”, a characteristic also found inpeople with schizophrenia. Moreau has

gone one step further and used thismodel to test antipsychotic drugs.Clozapine, olanzapine, and risperidonereverse the defects in PPI whereashaloperidol does not, a situation thatreflects the clinic where some patientsonly respond to atypical antipsychotics.

But how well does this modelmimic real life? Of course, people withschizophrenia have not had a hippo-campal injection of toxin shortly afterbirth, but they often have perinatalcomplications, low birth weight, orhypoxia. “You could imagine that this lesion in the hippocampus [in rats] is crudely modeling what mighthappen to the hippocampus of ahuman as a result of some obstetricevent causing hypoxia”, says RobinMurray (Institute of Psychiatry,London, UK).

The added bonus of looking atanimal models is that some rodentstrains are more susceptible toenvironmental triggers than others—apowerful indication that genes deal thedeciding hand. Yet opinions remaindivided as to how much is attributableto genetics. Murray insists that genesand early environmental insults,separately, are not enough. “Clearly lotsof the population are born prematurelyor with complications and neverdevelop schizophrenia. However, theeffects of such hazards on an individualwith genetic predisposition seems toresult in aberrant brain circuitry whichcannot cope with stresses such asisolation or drug abuse”, he says.

Will it ever be possible to modelschizophrenia? It is unlikely thatresearchers will ever know whether arat hallucinates or a mouse hears alienvoices. Schizophrenia is such a com-plex disorder that, in practice, it maybe impossible to mimic all thesymptoms in a single animal.

Despite the limitations, currentmodels are already providing somenew insights. “The animal models aremore sophisticated than I hadanticipated”, says Murray. “My viewused to be that it was too ambitious tomodel schizophrenia. But I now seethat you don’t model schizophreniabut aspects of the syndrome.”Lisa Melton

Modelling the schizophrenic brain

Newsdesk

Shrunken hippocampi in schizophrenia

Dr

Nan

cy C

And

reas

en/S

cien

ce P

hoto

Lib

rary

Rights were notgranted to include this

image in electronicmedia. Please refer to

the printed journal.